Cheng Zhang Ph.D.

SVP, Chief Scientist Office

Ph.D. of University of California at San Diego; Postdoc at MIT with Nobel Laureate Prof. Gobind Khorana; Professor Level Senior Engineer; Visiting Professor at Sichuan University;

30-year biopharmaceutical research and development experiences at MIT, NIH, Millennium Pharmaceuticals and Amgen. Dr. Cheng joined GMAX in 2011 and has been leading the GPCR/M-body research effort since then.
Rich experiences in developing antibody drugs targeting complex receptors. 28 publications and 17 patents.